Avandia Articles

Are Diabetic Native Americans at Greater Risk for Actos Side Effects, too?

November 16, 2011. By Abi Kistler.

Tempe, AZ: November is National Diabetes Month and according to the American Diabetes Association (ADA, www.diabetes.org), there are roughly 26 million Americans living with diabetes—and another 79 million at high risk of developing type 2 diabetes. The numbers are startling—in fact, every 17 seconds someone is diagnosed with diabetes, and the disease kills more people than breast cancer and AIDS combined each year. According to the Centers for Disease Control (CDC), diabetes is the seventh leading cause of death in the US.

Read [ Are Diabetic Native Americans at Greater Risk for Actos Side Effects, too? ]

GSK To Pay $3 Billion to Settle Avandia Claims

November 3, 2011. By Lucy Campbell.

Washington, DC: A $3 billion settlement has been reached between GlaxoSmithKline, the maker of the controversial diabetes medication Avandia, and federal authorities, ending investigations into whether or not the company marketed drugs for unapproved uses, among other charges.

Read [ GSK To Pay $3 Billion to Settle Avandia Claims ]

FDA Asks for Actos Bladder Cancer Warning

June 16, 2011. By Gordon Gibb.

Washington, DC: The one-time benefactor of the strife afflicting Avandia is having troubles of its own, now that the US Food and Drug Administration (FDA) has postulated that Actos is in need of a warning pertaining to the risk for bladder cancer—especially if the Type 2 diabetes drug is used for longer than a year.

Read [ FDA Asks for Actos Bladder Cancer Warning ]

Restrictions Announced in Avandia Use

May 25, 2011. By Heidi Turner.

Seattle, WA: Eight months after the US Food and Drug Administration (FDA) announced that restrictions would be imposed on Avandia use, the federal government has announced how those restrictions will look. Limitations on the use of Avandia were announced after concerns about Avandia side effects were raised. Those Avandia risks included a reported increased risk in heart attack. Now, concerns are also being raised about risks associated with rival drug Actos, according to J. Benton Stewart II, attorney at Stewart Law, P.L.L.C.

Read [ Restrictions Announced in Avandia Use ]

Drugmaker Sued over Failure to Warn of Avandia Side Effects

March 13, 2011. By Charles Benson.

New Orleans, LA: Drugmaker GlaxoSmithKline has been hit with another lawsuit over accusations that it did not properly warn of Avandia side effects, the Louisiana Record reports.

Read [ Drugmaker Sued over Failure to Warn of Avandia Side Effects ]

GlaxoSmithKline Faces Louisiana Lawsuit Over Avandia; Reportedly Settles Other Lawsuits

February 22, 2011. By Heidi Turner.

Baton Rouge, LA: Now that the label for Avandia has been changed and stricter rules are in place regarding Avandia's uses, another lawsuit has been filed alleging GlaxoSmithKline hid Avandia side effects from users. This time, however, the plaintiff alleging serious Avandia risks is not a patient but Louisiana Attorney General Buddy Caldwell.

Read [ GlaxoSmithKline Faces Louisiana Lawsuit Over Avandia; Reportedly Settles Other Lawsuits ]

Drugmaker Settles Avandia Heart Attack Lawsuit Prior to Trial

February 16, 2011. By Charles Benson.

Philadelphia, PA: Drugmaker GlaxoSmithKline recently settled an Avandia heart attack lawsuit just before it was scheduled to go to trial, Reuters reports.

Read [ Drugmaker Settles Avandia Heart Attack Lawsuit Prior to Trial ]

New FDA Restrictions Now Reflected on Avandia Label

February 8, 2011. By Gordon Gibb.

Washington, DC: Severe restrictions on Avandia announced in September by the US Food and Drug Administration (FDA) have finally made their way to the Avandia product label. According to a report by The Associated Press (AP) last night, the Avandia label (for US product) reflects the FDA recommendations that the Type 2 Diabetes drug is only intended for patients who are unable to control their blood sugar levels with any other diabetes medication.

Read [ New FDA Restrictions Now Reflected on Avandia Label ]

Drugmaker's Legal Costs Increase Due to Avandia Claims

January 26, 2011. By Charles Benson.

London, England: The UK's largest drugmaker, GlaxoSmithKline, recently said that it will incur legal costs of $3.5 billion in the fourth quarter due to liability cases associated with its diabetes drug Avandia, Bloomberg reports.

Read [ Drugmaker's Legal Costs Increase Due to Avandia Claims ]

Avandia: "Substantial" New Cases Since the Summer

January 20, 2011. By Gordon Gibb.

Philadelphia, PA: A Type 2 diabetes drug that was once the best-selling drug of its kind in the world continues to present legal and financial issues for its manufacturer. GlaxoSmithKline (GSK) announced earlier this week that it would be taking a $3.4 billion charge with regard to Avandia in the wake of government investigations and lawsuits.

Read [ Avandia: "Substantial" New Cases Since the Summer ]

• Judge Allows Experts' Witnesses in Avandia Lawsuits By Lucy Campbell (Jan-20-11)
• GSK To Pay Billions More over Avandia By Lucy Campbell (Jan-18-11)
• Attorney: Don't Wait to File Avandia Claim By Heidi Turner (Jan-15-11)
• What Will 2011 Bring for Avandia? By Heidi Turner (Jan-7-11)
• Death Toll from French Drug Similar to Avandia Surpasses 2,000 By Charles Benson (Dec-25-10)
• Critic Says Avandia Should Be Banned By Heidi Turner (Dec-20-10)
• Makers of Avandia Sued by the State of Utah By Gordon Gibb (Dec-6-10)
• New Warnings Given for Avandia Risks By Charles Benson (Nov-26-10)
• Avandia: Do FDA Warnings Help Determine Whether a Medicine Should Be Prescribed? By Heidi Turner (Nov-19-10)
• Will New Potential Benefit Breathe New Life into Avandia? By Gordon Gibb (Nov-4-10)
• Avandia Heart Attacks Force FDA to Severely Restrict Drug's Use By Charles Benson (Oct-25-10)
• What Should Patients Do In Light of Avandia Restrictions? By Heidi Turner (Oct-15-10)
• Even With Restrictions on Avandia, FDA Still Cautious By Gordon Gibb (Oct-5-10)
• FDA Announces Severe Avandia Restrictions By Heidi Turner (Sep-23-10)
• British Medical Journal: Pull Avandia from Market By Charles Benson (Sep-20-10)
• Actos possibly linked to Bladder Cancer By Jane Mundy (Sep-19-10)
• Could Avandia Be Pulled from European Market? By Heidi Turner (Sep-12-10)
• UK Medical Agency Concerned About Avandia By Lucy Campbell (Sep-6-10)
• New Study Further Clouds Debate over Avandia By Gordon Gibb (Sep-3-10)
• Avandia Memo Reportedly Biased By Heidi Turner (Aug-25-10)
• TIME: Glaxo Knew of Avandia Heart Attack Risk By Charles Benson (Aug-21-10)
• The FDA's Avandia Decision By Heidi Turner (Aug-14-10)
• Avandia's Fate is Sealed, Says Doctor. "The Drug is Done" By Gordon Gibb (Aug-5-10)
• GlaxoSmithKline to Pay $460 Million to Avandia Plaintiffs By Heidi Turner (Jul-28-10)
• FDA Stops Avandia TIDE Trial By Lucy Campbell (Jul-21-10)
• GSK Settles 10,000 Avandia Suits for $460M By Lucy Campbell (Jul-14-10)
• FDA Panel Recommendations Could Be Serious Blow to Avandia By Heidi Turner (Jul-14-10)
• Expert Panel Finds Avandia Increases Risk for Heart Attack By Lucy Campbell (Jul-14-10)
• FDA Medical Reviewer Slams RECORD Trial Conclusions, Casting Further Doubt on Avandia By Gordon Gibb (Jul-9-10)
• Avandia Debate Continues at ADA Conference By Gordon Gibb (Jul-7-10)
• Bad News for Avandia from Two Big Studies By Lucy Campbell (Jun-28-10)
• Avandia Rejected in Germany By Heidi Turner (Jun-27-10)
• Concerns over Avandia Side Effects Prompt Critics to Call for Restructuring of the FDA By Charles Benson (Jun-18-10)
• More Damning News about Avandia One Month before FDA Review By Gordon Gibb (Jun-13-10)
• Avandia Increases Heart Risks and Deaths over Rival Drug By Jane Mundy (Jun-11-10)
• Critics Split on New Avandia Study By Heidi Turner (Jun-8-10)
• More Avandia Lawsuits Settled By Heidi Turner (Jun-2-10)
• Vitamin K Could Help Replace Use of Avandia for Potentially Diabetic Patients By Charles Benson (Jun-2-10)
• Two Sites Resign from Avandia TIDE Clinical Trial By Gordon Gibb (May-23-10)
• Another Critic Comes out Against Avandia Safety Trial By Heidi Turner (May-19-10)

Legal Help Now!

CLICK HERE

• Hot Legal Issues

• Class Actions
• Lawyer Directory
• Free Newsletter
• Legal Careers
• Email this Page to a Friend